Previous close | 2.2600 |
Open | 2.1901 |
Bid | 2.0000 x 1000 |
Ask | 2.3000 x 2200 |
Day's range | 2.0000 - 2.2700 |
52-week range | 1.1700 - 4.8600 |
Volume | |
Avg. volume | 21,191 |
Market cap | 65.096M |
Beta (5Y monthly) | -0.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.9810 |
Earnings date | 29 Jun 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 10.07 |
SHENZHEN, China, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the first half of 2022 before the U.S. market opens on Wednesday, August 17, 2022. The Company will host a conference call to discuss the Company’s financial performance at 8:00 AM Eastern Time (8:00 PM Beijing Time) on Au
SHENZHEN, China, July 20, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that the Company, founders and senior executives of the Company and investors entered into a share purchase agreement, a subscription agreement, a shareholders’ agreement and a cooperation agreement. THE SHARE PURCHASE AGREEMENT On July 20, 2022, the Company, Dr. Pengwu Zhou and
SHENZHEN, China, July 13, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, is pleased to announce that further to its press release on May 31, 2022, the Company has closed its previously announced private placement offering through the issuance of 21,413,276 ordinary shares of the Company (the “Subscription Shares”) to Hawyu (HK) Limited at a price of RMB4.67 per Subs